What the buyer wrote
The genetics core team wishes to trial a novel bench-top sequencing platform which can scan low diversity libraries with high quality (Q30>90%; Q40>90%), a low PhiX spike, providing 2B reads per run at low cost of purchase and low cost per run (<5 GBP/Gb) and the ability to operate on small and large scale reading projects. On the basis of market analysis it is believed competition is absent for technical reasons and the awarded supplier may offer the only current ‘out of the box’ single device which fulfils this specification within the project budget. A ten day stand-still period will be observed should an economic operator who has not been identified in the market engagement wish to cha…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Novel benchtop sequencing platform
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Where
- in Scotland
Who the buyer named
Lana Elder was the named contact on this notice.